About Biomedica

Simple and Precise, 6 Seconds to a safer tomorrow


Biomedica believes every woman deserves equal opportunities to lead a healthy life. We provide simple and precise AI medical solutions to improve women's health.

Leveraging expertise in medical artificial intelligence, Biomedica offers physicians and medical researchers straightforward yet accurate solutions to tackle the challenges of disease screening.
 
 

6 seconds to a safer tomorrow

DiseaseAI Screening Leading Brand

500+ Medical Institutions Worldwide

Presence in 13 Countries

Company Milestone

2026

  • Completed external clinical validation of AIXA® Osteo in Japan's clinical environment in partnership with Dokkyo Medical University Saitama Medical Center, with results published in the European Journal of Radiology.
  • Biomedica X1 Osteoporosis officially obtained regulatory registration approval in the Philippines.
  •  Launched an academic collaboration with Chiang Mai University Hospital in Thailand to conduct clinical validation of AIXA Osteoporosis.

2025

  • Received the National Innovation Award — International Innovation Award.
  • Awarded the "Digital Service Organization Capability Registration Certificate" by the Administration for Digital Industries, Ministry of Digital Affairs.
  • Obtained the IHE Japan interoperability connectathon certification.
  • Achieved ISO 27001 certification.
  • Flagship AI product AIXA® Osteo secured Marubeni Corporation (Japan) as its general distributor.

2024

  • Winner of the TITA 20th Taiwan Golden Root Award
  • Recipient of the SME Innovation Research Award
  • Selected as a finalist in the "Top 100 Startups" competition (Biotechnology, Pharmaceuticals, and Medical Devices category).
  • Certified in the Medical Imaging and Pathology track by the Taiwan Medical Informatics Joint Testing.
  • Obtained Thailand medical device approval and entered the local market
  • Obtained Indonesia medical device approval

2023

  • Certified by the Digital Industry Agency of the Ministry of Digital Affairs as an AI Technology Service Provider
  • Selected as a promising startup team in the AAMA AIoT Co-Creation Program, collaborating with Advantech, Chunghwa Telecom, and Syscom Group
  • Obtained Vietnam MOH medical device approvals

2022

  • Champion of the Intel AI Dev CUP x OpenVINO Toolkit Competition – Implementation Category
  • Obtained Singapore HSA medical device approval
  • Obtained TFDA medical device approval

2021

  • Recipient of the Corporate Social Responsibility (CSR) Award
  • The only approved AI Technology Service Provider (Precision Medicine) by the Industrial Development Bureau, Ministry of Economic Affairs
  • First Place in the Southern Taiwan Science Park Biomedical Cluster International Advancement Program (Smart Healthcare)
  • Winner of the SCSE AI50 Campaign
  • Honored with the Chinese Trustworthy Brand Gold Award
  • Obtained U.S. FDA certification
  • Obtained Singapore HSA Class A medical device approval
  • Established ISO and QMS medical materials factory in Southern Taiwan Science Park
  • Founding of Biomedica
TOP